What are the opening hours?

Monday 8am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Ametris

Name: Ametris
Address: Pensacola, FL, US
Telephone: +18503327900

Call Directions Website Contact the business

Pioneering the Digital Transformation of Clinical Research

10/29/2026

We are excited to announce Ametris is launching seven new DECODE initiatives: ALS, COPD, heart failure/cardiomyopathy, sleep disorders, depression, schizophrenia, and Parkinson’s disease.

What is DECODE? The Digital Endpoint Collaboration for Outcomes DEvelopment is Ametris' pre-competitive framework for solving shared clinical measurement challenges that no single organization can take on alone.

Each initiative brings together a distinct coalition of sponsors, clinicians, regulators, and patients working to generate the evidence needed and to validate regulatory-ready, digitally derived measures (DDM).

Advancing together, these new DECODE initiatives aim to accelerate Digital Health Technology (DHT) adoption and shorten the distance between innovation and the patients waiting for it.

Become a founding partner: https://hubs.la/Q04CMMTn0

10/27/2026

Last call to register for tomorrow's webinar! DECODE, the Digital Endpoint Collaboration for Outcomes DEvelopment, is Ametris' pre-competitive framework designed to mobilize the life sciences industry around shared clinical measurement challenges that no single organization can take on alone.

Digital measures used in clinical trials must be meaningful to patients, scientifically valid, operationally feasible, and regulatory aligned. The DECODE framework was developed to advance the development and validation of fit-for-purpose digital clinical measures for indications where traditional measurements fall short.

Through industry stakeholder consensus-building, patient engagement, clinical study and regulatory alignment, and shared evidence generation, each DECODE project aims to close these clinical measurement gaps, so patients get the treatments they need, faster.

📅Wednesday, October 28th, 2026
🕛12:00PM to 1:00PM EST

🎙️Speakers:
🔹Chad Gwaltney, PhD at Gwaltney Consulting
🔹Jonas Dorn, PhD at Roche
🔹Mark Morris, MBA at Johnson & Johnson
🔹Jeanine du Plessis, MSc at Signant Health
🔹Rakesh Pilkar, PhD at Ametris
🔹Sylvain Zorman, PhD at Ametris
🔹Christine Cong Guo, PhD at Ametris

Register today, and receive the recording after the event: https://hubs.la/Q04CtJ5D0

10/23/2026

For people living with COPD, understanding how symptoms affect daily life is an important starting point for patient-focused research.

Continuous monitoring of cough and cough exacerbations adds another perspective on the symptom burden patients experience between clinic visits.

In our latest on-demand respiratory webinar, explore the evidence base for wearables as a digital endpoint in COPD and how these complementary approaches can help researchers better understand patients’ everyday experiences.

▶️ Access the on-demand recording to your inbox: https://hubs.la/Q04Cd4h20

10/23/2026

10/20/2026

Digital measures used in clinical trials must be meaningful to patients, scientifically valid, operationally feasible, and regulatory aligned, yet some clinical measurement challenges may be too great for any one organization to solve alone.

It's why we created DECODE (Digital Endpoint Collaboration for Outcomes DEvelopment), Ametris' pre-competitive framework designed to mobilize the life sciences industry and to advance the development and validation of fit-for-purpose digital clinical measures for indications where traditional measurements may fall short.

Join us for our next Digital Health Monthly webinar to hear from:
🔹Chad Gwaltney, PhD at Gwaltney Consulting
🔹Jonas Dorn, PhD at Roche
🔹Lauren Crooks at Signant Health
🔹Rakesh Pilkar, PhD at Ametris
🔹Sylvain Zorman, PhD at Ametris
🔹Christine Guo, PhD at Ametris

📅 Wednesday, October 28th, 2026 | 12-1pm EST

Register here: https://hubs.la/Q04BR1zB0

10/15/2026

DECODE, the Digital Endpoint Collaboration for Outcomes DEvelopment, is Ametris' pre-competitive framework designed to mobilize the life sciences industry around shared clinical measurement challenges that no single organization can take on alone.

Digital measures used in clinical trials must be meaningful to patients, scientifically valid, operationally feasible, and regulatory aligned. The DECODE framework was developed to advance the development and validation of fit-for-purpose digital clinical measures for indications where traditional measurements fall short.

Through industry stakeholder consensus-building, patient engagement, clinical study and regulatory alignment, and shared evidence generation, each DECODE project aims to close these clinical measurement gaps, so patients get the treatments they need, faster.

This 60-minute session begins with an update on the regulatory landscape for Digitally Derived Measures. We’ll then introduce the DECODE framework and present key results from the first DECODE initiatives and the launch of new DECODE initiatives in respiratory, cardiometabolic, and neuroscience. We’ll wrap up the session with a multidisciplinary panel discussion of speakers from Brown University and Roche and a Q&A from the audience.

🎙️Speakers:
🔹Chat Gwaltney, PhD at Brown University
🔹Jonas Dorn, PhD at Roche
🔹Sylvain Zorman, PhD at Ametris
🔹Christine Guo, PhD at Ametris

Join us Wednesday, October 28th, 2026 at 12-1pm EST for our next Digital Health Monthly. Register for the webinar: https://hubs.la/Q04BjwPQ0

10/13/2026

Our new whitepaper, Modernizing Respiratory Endpoints, presents the supporting evidence and regulatory precedent for continuous, wearable-based measures in respiratory clinical development, along with considerations for sponsors evaluating endpoint strategy.

Access the whitepaper: https://hubs.la/Q04B2y0C0

10/12/2026

🚨 Registration is now open for the Ametris Digital Data Summit 2027! 🚨

Join us in Atlanta, Georgia again this year on February 8-10 to work together towards broader adoption of digital health technology to advance clinical research.

Highlights in this year's agenda will build on successful and engaging elements of previous events, including dedicated networking, data-focused presentations, and expert panel discussions.

✨ CALL FOR ABSTRACTS! ✨ Submit abstracts for the Scientific Poster Session and for a chance at a short oral presentation (5-7 minutes). The deadline is extended to Friday, October 30, 2025.

Register today through October 31 and take advantage of Early Bird pricing, with discounts up to 40% off the standard rate!

You can visit the ADDS Atlanta 2027 homepage using the link in the comments ⤵️ to submit your abstract, review speaker information and see event details. Watch the short video below to hear from last year's attendees.

10/08/2026

Hurricane Update: Our Pensacola, Florida headquarters will be closed Friday, October 9th, due to the anticipated impacts of Hurricane Isaias in the Gulf Coast area. This a physical office closure, but it remains business as usual for all those outside of the Pensacola/affected area. Ametris team members will be working remotely until noon; however, shipping delays should be expected during this time.

We anticipate resuming regular business hours on Monday, October 12th, pending weather conditions and any storm-related impacts. Should there be any changes or delays, we will continue to share updates as they become available. If you need immediate assistance, please contact us by email at [email protected], and we will respond as quickly as possible. Thank you for your patience!

10/01/2026

October 2nd is the final deadline to submit abstracts for short talk opportunities at ADDS 2027 (Feb 8–10, 2027).

For researchers, data scientists, and clinical investigators driving advances in digital health, digitally derived measures, and more, this is an opportunity to put your evidence directly in front of leading peers, clinical sponsors, and industry decisionmakers.

Why submit before tomorrow's deadline?
✅ Oral Presentation Track: Selected abstracts will be awarded dedicated short talk slots (5-7 min) during primary track sessions, offering direct visibility for ongoing or completed research.
✅ Poster Hall Exhibition: Accepted submissions receive dedicated poster hall placement for high-engagement networking.
✅ Interdisciplinary Reach: Share methodologies and data with a target audience of biopharma leaders, principal investigators, and experts in academia.

We welcome submissions covering the use of a digital health technology (DHT) — sensor, wearable and/or eCOA. Deadline for Short Talk Consideration: Tomorrow, October 2nd at 11:59 PM EST

Submit your abstract here: https://hubs.la/Q04yZvj20

Address

Pensacola, FL

Opening Hours

Monday	8am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Telephone

+18503327900

Website

http://www.ametris.com/

Alerts

Be the first to know and let us send you an email when Ametris posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.